Initial experience of robotic-assisted laparoendoscopic single site intraligamental myomectomy ambulatory surgery—report of two cases

Intelligent Surgery Pub Date : 2023-01-01 DOI:10.1016/j.isurg.2023.07.002

Xueli Hu , Mengjia Ruan , Shuangwei Zou , Min Huang , Lili Lin , Wenwen Zheng , Xueqing Bao , Lifang Qi , Lizhi Wang , Ping Duan

{"title":"Initial experience of robotic-assisted laparoendoscopic single site intraligamental myomectomy ambulatory surgery—report of two cases","authors":"Xueli Hu , Mengjia Ruan , Shuangwei Zou , Min Huang , Lili Lin , Wenwen Zheng , Xueqing Bao , Lifang Qi , Lizhi Wang , Ping Duan","doi":"10.1016/j.isurg.2023.07.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To analyze and summarize the experience of single-port robotic-assisted laparoscopic ambulatory surgery (AS) for intraligamental myomectomy.</p></div><div><h3>Methods</h3><p>We analyzed the basic conditions, preoperative myoma assessment, surgical operation, and perioperative management of two patients undergoing robotic-assisted laparoendoscopic single site (R-LESS) intraligamental myomectomy and reviewed in the literature to summarize the initial clinical experience of the robotic AS model.</p></div><div><h3>Results</h3><p>Two cases of R-LESS intraligamental myomectomy were successfully discharged after 29.82 h and 25.95 h of hospitalization, respectively, with no complications.</p></div><div><h3>Conclusion</h3><p>R-LESS intraligamental myomectomy to achieve AS is safe and feasible. Adequate preoperative myoma evaluation, staging and strict access criteria, combined with current advanced single-port robotic technology and meticulous intraoperative management, and a scientific perioperative Enhanced Recovery After Surgery (ERAS) management process are vital factors to enable AS for intraligamental myomectomy.</p></div>","PeriodicalId":100683,"journal":{"name":"Intelligent Surgery","volume":"6 ","pages":"Pages 42-49"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligent Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266667662300008X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

To analyze and summarize the experience of single-port robotic-assisted laparoscopic ambulatory surgery (AS) for intraligamental myomectomy.

Methods

We analyzed the basic conditions, preoperative myoma assessment, surgical operation, and perioperative management of two patients undergoing robotic-assisted laparoendoscopic single site (R-LESS) intraligamental myomectomy and reviewed in the literature to summarize the initial clinical experience of the robotic AS model.

Results

Two cases of R-LESS intraligamental myomectomy were successfully discharged after 29.82 h and 25.95 h of hospitalization, respectively, with no complications.

Conclusion

R-LESS intraligamental myomectomy to achieve AS is safe and feasible. Adequate preoperative myoma evaluation, staging and strict access criteria, combined with current advanced single-port robotic technology and meticulous intraoperative management, and a scientific perioperative Enhanced Recovery After Surgery (ERAS) management process are vital factors to enable AS for intraligamental myomectomy.

查看原文本刊更多论文

机器人辅助腹腔镜单部位韧带内肌瘤切除术的初步经验-附2例报告

目的分析总结单孔机器人辅助腹腔镜门诊手术治疗韧带内肌瘤的经验。方法分析2例机器人辅助腹腔镜单部位(R-LESS)韧带内肌瘤切除术患者的基本情况、术前肌瘤评估、手术操作及围手术期处理，并复习文献，总结机器人AS模型的初步临床经验。结果2例R-LESS韧带内肌瘤切除术患者分别在住院29.82 h和25.95 h后顺利出院，无并发症发生。结论r - less韧带内肌瘤切除术治疗AS是安全可行的。充分的术前肌瘤评估、分期和严格的准入标准，结合当前先进的单孔机器人技术和细致的术中管理，以及科学的围手术期ERAS管理流程，是使AS能够用于韧带内肌瘤切除术的重要因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Intelligent Surgery

自引率

0.00%

发文量